Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 4071-4078

  Inouye, Roger T ^a   Du, Bin ^a   Boldt Houle, Deborah ^a   Ferrante, Anthony ^a   Park, In Woo ^a   Hammer, Scott M ^a   Duan, Lingxun ^b   Groopman, Jerome E ^a   Pomerantz, Roger J ^b   Terwilliger, Ernest F ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; REGULATOR PROTEIN; REV PROTEIN;

ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; T LYMPHOCYTE; VIRUS INHIBITION;

EID: 0030978207     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.4071-4078.1997     Document Type: Article

References (40)

1. Baltimore, D. 1988. Intracellular immunization. Nature 335:395-396.
2. Bartel, D. P., M. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
3. Chalfie, M., Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher. 1994. Green fluorescent protein as a marker for gene expression. Science 263:802-805.
4. Chatterjee, S., P. R. Johnson, and K. K. Wong, Jr. 1992. Dual target inhibition of HIV-1 in vitro by means of an AAV anti-sense vector. Science 258:1485-1488.
5. Cullen, B. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
6. Du, B., A. Wolf, and E. Terwilliger. 1993. Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene. Virology 195:260-264.
7. Du, B., P. Wu, D. M. Boldt-Houle, and E. Terwilliger. 1996. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3: 254-261.
8. Duan, L., O. Bagasra, M. Laughlin, J. Oakes, and R. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus replication by an intracellular anti-Rev single-chain antibody. Proc. Nati. Acad. Sci. USA 91:5075-5079.
9. Duan, L., H. Zhang, J. W. Oakes, O. Bagasra, and R. J. Pomerantz. 1994. Molecular and virological effects of intracellular anti-rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum. Gene Ther. 5:1315-1324.
10. Duan, L., M. Zhu, O. Bagasra, and R. J. Pomerantz. 1995. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments. Hum. Gene Ther. 6:1561-1573.
11. Ehrlich, G. D., S. Greenberg, and M. A. Abbott. 1990. Detection of human T-cell lymphoma/leukemia viruses, p. 325-336. In M. A. Innis. D. H. Gelfland, J. T. Srinsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
12. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
13. Flotte, T. R., S. A. Afione, C. Conrad, S. A. McGrath, R. Solow, H. Oka, P. L. Zeitlin, W. B. Guggino, and B. J. Carter. 1993. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617.
14. Giver, L., D. Bartel, M. Zapp, A. Pawul, M. Green, and A. D. Ellington. 1993. Selective optimization of the Rev-binding element of HIV-1. Nucleic Acids Res. 21:5509-5516.
15. Goodman, S., X. Xiao, R. E. Donahue, A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant AAV-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
16. Graham, F. L., J. Smiley, W. C. Russell, and R. Naiva. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
17. Halbert, C. L., I. E. Alexander, G. M. Wolgamot, and A. D. Miller. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69:1473-1479.
18. Heim, R., D. C. Prasher, and R. Y. Tsien. 1994. Wavelength mutations and posttranslational autooxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA 91:12501-12504.
19. Hoffman, M. A., and A. C. Palmenberg. 1995. Mutational analysis of the J-K stem-loop region of the encephalomyocarditis virus IRES. J. Virol. 69:4399-4406.
20. Jolly, D. 1994. Viral vector systems for gene therapy. Cancer Gene Ther. 1:55-64.
21. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
22. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
23. Kubota, S., L. Duan, R. A. Furuta, M. Hatanaka, and R. J. Pomerantz. 1996. Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein. J. Virol. 70:1282-1287.
24. McLeod, G. X., J. M. McGrath, E. A. Ladd, and S. M. Hammer. 1992. Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay. Antimicrob. Agents Chemother. 36:920-925.
25. Miller, J. L., R. E. Donahue, S. E. Sellers, R. J. Samulski, N. S. Young, and A. W. Nienhuis. 1994. Recombinant AAV-mediated expression of a human gamma-globulin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91:10183-10187.
26. Muro-Cacho, C. A., R. J. Samulski, and D. Kaplan. Gene transfer in human lymphocytes using a vector based on AAV. 1992. J. Immunother 11:231-237.
27. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-131.
28. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
29. Pinkston, P., N. Pelletier, C. Arena, J. Schock, R. Garland, and R, M. Rose. 1995. Quantitative culture of HIV-1 from bronchoalveolar lavage cells. Am. J. Respir. Crit. Care Med. 152:254-259.
30. Pomerantz, R. J., T. Seshamma, and D. Trono. 1992. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. J. Virol. 66:1809-1813.
31. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
32. Pritchard, C. E., J. A. Grasby, F. Hamy, A. M. Zacharek, M. Singh, J. Karn, and M. J. Gait. 1994. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins. Nucleic Acids Res. 22:2591-2600.
33. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
34. Samulski, R. J., L. S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.
35. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
36. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, L. Thompson, and C. A. Rosen. 1992. HIV regulatory proteins: potential targets for therapeutic intervention. AIDS Res. Hum. Retroviruses 8:175-181.
37. Vella, S. 1995. Clinical experience with saquinavir. AIDS 9:S21-S25.
38. Woffendin, C., Z. Y. Yang, Udaykumar, L. Xu, N. S. Yang, M. J. Sheehy, and G. J. Nabel. 1994. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T-cells. Proc. Natl. Acad. Sci. USA 91:11581-11585.
39. Wu, Y., L. Duan, M. Zhu, B. Hu, S. Kubota, O. Bagasra, and R. J. Pomerantz. 1996. Binding of intracellular anti-Rev single-chain variable fragments to different epitopes of human immunodeficiency virus type 1 Rev: variations in viral inhibition. J. Virol. 70:3290-3297.
40. Xiao, X., W. deVlaminck, and J. Monahan. 1993. Adeno-associated virus (AAV) vectors for gene transfer. Adv. Drug Del. Rev. 12:201-215.